{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:24:06Z","timestamp":1765232646135,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bbmt.2018.10.014","type":"journal-article","created":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T12:09:37Z","timestamp":1540210177000},"page":"587-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lymphocyte Area Under the Curve as a Predictive Factor for Viral Infection after Allogenic Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4030-4653","authenticated-orcid":false,"given":"Mizuki","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Hishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8959-6271","authenticated-orcid":false,"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouhei","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-4284","authenticated-orcid":false,"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2018.10.014_bib0001","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0002","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2008.386","article-title":"Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia","volume":"43","author":"Styczynski","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2018.10.014_bib0003","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1038\/bmt.2008.120","article-title":"CMV infections after hematopoietic stem cell transplantation","volume":"42","author":"Ljungman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0004","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","article-title":"How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients","volume":"128","author":"El Chaer","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1399-3062.2012.00727.x","article-title":"L-index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Kimura","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0006","unstructured":"The Japan Society for Hematopoietic Cell transplantation, Japanese Guideline for CMV infection. https:\/\/www.jshct.com\/guideline\/pdf\/guideline_CMV_2.pdf. 2011; Accessed April 9, 2018"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0007","doi-asserted-by":"crossref","unstructured":"Takenaka K, Gondo H, Tanimoto K, et al. Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. Fukuoka Bone Marrow Transplantation Group. Bone Marrow Transplant. 1997;19:241-248.","DOI":"10.1038\/sj.bmt.1700637"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0008","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1702805","article-title":"Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan","volume":"27","author":"Kanda","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0009","doi-asserted-by":"crossref","unstructured":"Boeckh M, Bowden RA, Goodrich JM, Pettinger M, Meyerst JD. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood. 1992;80:1358-1364.","DOI":"10.1182\/blood.V80.5.1358.bloodjournal8051358"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0010","doi-asserted-by":"crossref","unstructured":"Mori T, Okamoto S, Matsuoka S, et al. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000;25:765-769.","DOI":"10.1038\/sj.bmt.1702227"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0011","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/jmv.24161","article-title":"Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation","volume":"87","author":"Inazawa","year":"2015","journal-title":"J Med Virol"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0012","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/bmt.2008.162","article-title":"Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT","volume":"42","author":"Ljungman","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0013","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/599829","article-title":"Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study","volume":"49","author":"Cesaro","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0014","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jiac.2016.01.013","article-title":"Successful treatment with intravesical cidofovir for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: a case report and a review of the literature","volume":"22","author":"Sakurada","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0015","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1704682","article-title":"Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients","volume":"34","author":"Nagafuji","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0016","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0017","doi-asserted-by":"crossref","unstructured":"Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. 1988;16:1141-1154.","DOI":"10.1214\/aos\/1176350951"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0018","doi-asserted-by":"crossref","unstructured":"Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. 1999;94:496-509.","DOI":"10.1080\/01621459.1999.10474144"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0019","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software EZR for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.12682","article-title":"Risk factors of human herpesvirus 6encephalitis\/myelitis after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Miyashita","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0021","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cid\/cit358","article-title":"Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study","volume":"57","author":"Ogata","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0022","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbmt.2011.12.579","article-title":"Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study","volume":"18","author":"Dulery","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0023","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.bbmt.2015.07.022","article-title":"Impact of human herpesvirus-6 reactivation on outcomes of allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Aoki","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbmt.2011.07.018","article-title":"The complex relationship between human herpesvirus 6 and acute graft-versus-host disease","volume":"18","author":"Pichereau","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/TP.0b013e318289958b","article-title":"Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation","volume":"95","author":"Jeulin","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0026","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1182\/blood.V100.6.2005","article-title":"High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients","volume":"100","author":"Sashihara","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0027","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/tid.12049","article-title":"Human herpesvirus-6 encephalitis during hematopoietic stem cell transplantation leads to poor prognosis","volume":"15","author":"Shimazu","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0028","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/MOT.0b013e3283404325","article-title":"Infections due to human herpesvirus 6 in solid organ transplant recipients","volume":"15","author":"Razonable","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0029","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1083-8791(00)70010-3","article-title":"CMV antigenemia following bone marrow transplantation: risk factors and outcomes","volume":"6","author":"Osarogiagbon","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1399-3062.2011.00706.x","article-title":"A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group","volume":"14","author":"George","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0031","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jinf.2015.09.039","article-title":"HHV-6 infection after allogeneic hematopoietic stem cell transplantation: from chromosomal integration to viral co-infections and T-cell reconstitution patterns","volume":"72","author":"Quintela","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0032","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/bloodadvances.2017012724","article-title":"Human herpesvirus 6 viremia affects T-cell reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"2","author":"de Koning","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.bbmt.2018.10.014_bib0033","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/v9120367","article-title":"The interplay between natural killer cells and human herpesvirus-6","volume":"9","author":"Eliassen","year":"2017","journal-title":"Viruses"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118306475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118306475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:05:50Z","timestamp":1761059150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118306475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1083879118306475"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.10.014","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocyte Area Under the Curve as a Predictive Factor for Viral Infection after Allogenic Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}